V
Vistagen Therapeutics, Inc. (VTGN)
NCM – Real Time Price. Currency in USD
0.70
+0.09 (13.85%)
At close: Jun 26, 2026, 4:00 PM EDT
0.74
+0.04 (5.41%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.70
+0.09 (13.85%)
At close: Jun 26, 2026, 4:00 PM EDT
0.74
+0.04 (5.41%)
After-hours: Jun 26, 2026, 7:59 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $30.8M significantly exceed its total debt $1.0M, ensuring strong financial flexibility
Total current assets $46.9M exceed Total current liabilities $12.8M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$16.2M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.67 | 6.05 | 10 | |
| Quick ratio | 3.67 | 5.63 | 10 | |
| Debt to Equity | 0.03 | 0.30 | 9.0 | |
| Debt to Assets | 0.02 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | -227K | 1M | 486K | 1M | 1M |
| Gross Profit | -737K | 496K | -149K | 536K | 537K |
| Operating Income | -59M | -33M | -56M | -72M | -72M |
| Net Income | -59M | -29M | -51M | -70M | -70M |
| EBITDA | -59M | -32M | -55M | -71M | -71M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 104.92 | 22.34 | 10 |
| Next quarter | 93.8 | 30.56 | 10 |
| Current year | -25.14 | 19.4 | 5.0 |
| Next year | -100 | -4.41 | 1.0 |
| Weighted average score | 6.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 53.47 | 13.89 | 17.78 | 8.25 | 8.3 |
| Y/Y | 98.72 | -15.5 | 19.57 | -57.58 | 5.3 |
| 3y average | 224.97 | -20.05 | 20.9 | -24.22 | 5.5 |
| 5y average | 111.24 | -50.1 | 19.65 | -70.11 | 5.3 |
| Weighted average score | 6.1 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |